Viewing Study NCT06442215



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06442215
Status: RECRUITING
Last Update Posted: 2024-06-05
First Post: 2024-05-29

Brief Title: Selection of Surgical Technique in Rectal Cancer
Sponsor: Institut dInvestigació Biomèdica de Girona Dr Josep Trueta
Organization: Institut dInvestigació Biomèdica de Girona Dr Josep Trueta

Study Overview

Official Title: Selection of Surgical Technique in Rectal Cancer Through the Development of a Predictive Model for Optimal Oncological Outcomes
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TECARE
Brief Summary: Currently there is no prediction scale available to identify patients with rectal neoplasms as technically complex in the middle and lower thirds that is those who are at high risk of affected circumferential margins and low quality of the mesorectum The application of a predictive model that allows preoperative identification of the group of patients in whom optimal results in mesorectal quality and circumferential margin are less likely to be obtained through laparoscopic or minimally invasive surgery would enable the selection of patients who will require and justify all efforts and healthcare resources to improve surgical outcomes

Therefore the investigators aim to create a predictive model to identify these patients allowing the discrimination of which patients will benefit from different techniques or even which ones would be opportune to initially consider an open approach
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None